DUBLIN, Ireland, May 26, 2017 -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate at the following conferences in June:
Jefferies 2017 Global Healthcare Conference
- Date: June 6, 2017
- Presentation Time: 11:30 a.m. ET
- Location: New York, NY
The JMP Securities Life Science Conference
- Presentation Date: June 21, 2017
- Presentation Time: 1:30 p.m. ET
- Location: New York, NY
The conferences presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
| Investors: | U.S. Media: |
| Tina Ventura | Geoff Curtis |
| Senior Vice President, | Senior Vice President, |
| Investor Relations | Corporate Affairs & Chief Communications Officer |
| [email protected] | [email protected] |
| Ruth Venning | Ireland Media: |
| Executive Director, | Ray Gordon |
| Investor Relations | Gordon MRM |
| [email protected] | [email protected] |


Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 



